Release date: 2009-02-20
A new study published this month in the internationally renowned medical journal Emergency Medical Yearbook shows that the use of advanced bedside rapid diagnostic equipment can help doctors quickly diagnose chest pain in patients, saving an average of 20 minutes on detection time, thus saving the heart. The patient wins the best time.
The report entitled "Multi-channel Randomized Control of Central Laboratory and Rapid Diagnosis of Cardiac Disease Detection Strategies: The Impact of Rapid Diagnostic Marks in the Acute Coronary Syndrome Test Series" report, Dr. Richard Ryan, Deputy Director, Department of Emergency Medicine, University of Cincinnati Medical School, USA leadership. A randomized controlled clinical trial of a bedside rapid diagnostic instrument was performed for the first time in 2000 patients with chest pain or suspected acute coronary syndrome.
The study was completed by four well-known emergency departments at the Jewish Hospital in Cincinnati, William Beaumont Hospital in Detroit, the University of Pennsylvania, and Stanford University. The study showed that compared to the traditional detection process of the “emergency room-laboratory-emergency roomâ€, handheld diagnosis The tool Abbott i-STAT provides instant laboratory quality testing results, with an average of 20 to 45 minutes to reach the doctor.
According to the guidelines recommended by the American Heart Association, the European Heart Association, and the National Association of Clinical Biochemistry, the blood volume should be less than 60 minutes from the time the patient is sampled, and the optimal turnaround time should be within 30 minutes. “This time is very valuable for patients with myocardial death.†Dr. Christopher J. Lindsell, one of the researchers at the University of Cincinnati Medical Center, said: “The i-STAT patient bedside rapid diagnostics represents a new medical trend. To help doctors develop treatment plans faster." - Shanghai Medical Device Industry Association
We are a manufacturer and supplier of raw materials and intermediates for pharmaceuticals. Our focus is on providing customers with high quality, fair priced products, coupled with our broad range of technical know-hows on fundamentals, vast industrial experience on applications, professional expertise on health and safety, and efficient logistics on customer services. Our intermediates products range covers many different kinds of API, we have established good market for our intermediates in India, Korea and EU. Besides the products of Ziprasidone Intermediates, Ibrutinib Intermediates, Lcz696 Intermediates , Palbociclib Intermediates and Tazobactam intermediates, we have other strong intermediates like Tazobactam Intermediate with CAS No. 288-36-8.
All of our products are with stable production and strict quality control, making sure your experience with Sunshine Biotech is always enriching, satisfying and fulfilling.
Other Intermediates
Other Intermediates,Tazobactam Intermediate,Pharmaceutical Intermediates,Dye Intermediate
Nanjing Sunshine Biotech Co., Ltd , http://www.sunshine-bio.com